AI Article Synopsis

  • The US Nuclear Regulatory Commission (NRC) and 38 Agreement States regulate the use of radioisotopes in medicine, focusing on training and experience requirements for users outlined in 10CFR35.390.
  • The NRC is currently reviewing major revisions to these training and experience regulations.
  • The article discusses the existing regulations, concerns regarding the proposed changes, and the response from the American College of Radiology (ACR).

Article Abstract

The US Nuclear Regulatory Commission (NRC) and 38 Agreement States have the regulatory authority to promulgate and enforce regulations related to the use of radioisotopes for medical purposes. Elements of these regulations include training and experience (T&E) requirements for individuals authorized to use the agents. These regulations are specified in 10CFR35.390. At this time, the NRC is considering significant revisions to the T&E requirements. This article describes current regulations and concerns related to the proposed changes and details the ACR organizational response.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2019.04.010DOI Listing

Publication Analysis

Top Keywords

t&e requirements
8
training education
4
education requirements
4
requirements authorized
4
authorized users
4
users therapeutic
4
therapeutic radiopharmaceuticals
4
radiopharmaceuticals changes
4
changes consideration
4
consideration 10cfr35390
4

Similar Publications

Engineering an optimized hypercompact CRISPR/Cas12j-8 system for efficient genome editing in plants.

Plant Biotechnol J

January 2025

Key Laboratory of Herbage and Endemic Crop Biology, Ministry of Education, Inner Mongolia University, Hohhot, China.

The Cas12j-8 nuclease, derived from the type V CRISPR system, is approximately half the size of Cas9 and recognizes a 5'-TTN-3' protospacer adjacent motif sequence, thus potentially having broad application in genome editing for crop improvement. However, its editing efficiency remains low in plants. In this study, we rationally engineered both the crRNA and the Cas12j-8 nuclease.

View Article and Find Full Text PDF

Backgrounds And Aims: CD8+T cells are crucially associated with the fight against hepatitis B virus (HBV) infection. CD161 has been shown to express remarkably on HCV-specific CD8+T cells. However, the accurate function of CD161+CD8+T cells in HBV immunity or pathogenesis remains undetermined.

View Article and Find Full Text PDF

Angiogenesis begins as endothelial cells migrate, forming a sprouting tip and subsequent growth-rich stalk cells. Here, we present a protocol for transcriptomic and epigenomic analyses of tip-like cells in cultured endothelial cells. We describe steps for stimulating human umbilical vein endothelial cells (HUVECs) with vascular endothelial cell growth factor (VEGF) to generate tip-like cells.

View Article and Find Full Text PDF

IL-7 promotes integrated glucose and amino acid sensing during homeostatic CD4 T cell proliferation.

Cell Rep

January 2025

School of Infection, Inflammation and Immunology, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Electronic address:

Interleukin (IL)-7 promotes T cell expansion during lymphopenia. We studied the metabolic basis in CD4 T cells, observing increased glucose usage for nucleotide synthesis and oxidation in the tricarboxylic acid (TCA) cycle. Unlike other TCA metabolites, glucose-derived citrate does not accumulate upon IL-7 exposure, indicating diversion into other processes.

View Article and Find Full Text PDF

Early cancer detection substantially improves the rate of patient survival; however, conventional screening methods are directed at single anatomical sites and focus primarily on a limited number of cancers, such as gastric, colorectal, lung, breast, and cervical cancer. Additionally, several cancers are inadequately screened, hindering early detection of 45.5% cases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!